Detlev Zwingmann-Cornelius

Lead Quality Engineer Combination Products & Medical Devices
CSL Behring
Marburg, Hessen, Germany

Presentation(s):

• PB1178 - Validation of a neutralizing antibody (NAb) assay with extended reportable range for etranacogene dezaparvovec, an adeno-associated virus serotype 5 (AAV5)-based gene therapy for adult hemophilia B

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT